Phenylcarbamic acid esters
![eMolecules 1373273-46-1 | {1-[(tert-Butoxy)carbonyl]pyrrolo[3,2-b]pyridin-2-yl}boronic acid | Ambeed | MFCD30182376 | 262.070 | C12H15BN2O4 | 95.000 | CC(C)(C)OC(=O)n1c(cc2ncccc12)B(O)O | 5g | 573002114](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000280261.jpg-250.jpg)
eMolecules 1373273-46-1 | {1-[(tert-Butoxy)carbonyl]pyrrolo[3,2-b]pyridin-2-yl}boronic acid | Ambeed | MFCD30182376 | 262.070 | C12H15BN2O4 | 95.000 | CC(C)(C)OC(=O)n1c(cc2ncccc12)B(O)O | 5g | 573002114
{1-[(tert-Butoxy)carbonyl]pyrrolo[3,2-b]pyridin-2-yl}boronic acid | Ambeed | 1373273-46-1 | MFCD30182376 | 262.070 | C12H15BN2O4 | 95.000 | CC(C)(C)OC(=O)n1c(cc2ncccc12)B(O)O | 5g | 573002114
Medchemexpress LLC Acid-PEG3-C2-Boc | 1807539-06-5 | ≥97.0% | 100 MG
Acid-PEG3-C2-Boc is a PEG- and Alkyl/ether-based PROTAC linker. It can be used in the synthesis of PROTACs for the degradation of EGFR and inhibition of mTOR. PROTACs utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- Peg- and alkyl/ether-based protac linker
- Can be used in the synthesis of protacs
- Potential for degradation of egfr
- Potential for inhibition of mtor
Medchemexpress LLC Boc-C14-COOH | 843666-27-3 | ≥98.0% | 342.51 g/mol | C20H38O4 | 5 G
Boc-C14-COOH is a Boc-protected C14 carboxylic acid used as a non-cleavable linker in antibody-drug conjugate (ADC) synthesis and as an alkyl chain linker in PROTAC construction. It is supplied as a powder with characterized solubility and storage recommendations.
- Used as a non-cleavable ADC linker and PROTAC linker.
- Powder form with specified storage conditions for powder and solutions.
- Soluble in DMSO (200 mg/mL) for in vitro use; formulations for in vivo use are documented.
- Molecular weight 342.51 g/mol and formula C20H38O4 for formulation calculations.
- Available in small laboratory quantities and larger pack sizes per vendor listing.
Cayman Chemical N ketocaproylLHomoserine lac
A bacterial quorum-sensing signaling molecule; produced in the marine bioluminescence bacterium V. fischeri
Medchemexpress LLC S100P Human N-His 100ug
Recombinant human S100P protein with an N-terminal 6xHis tag, expressed in E. coli and supplied as a lyophilized powder. Purified to >95% by reducing SDS-PAGE and supplied in a 100 μg package with formulation designed for stability. The product is intended for in vitro research applications and is accompanied by a datasheet, COA, and SDS for batch-specific information.
- High purity (>95%) for reliable assay performance.
- N-terminal 6xHis tag for straightforward purification and detection.
- Lyophilized formulation with trehalose for extended shelf life.
- Low endotoxin (<1 EU/μg) suitable for sensitive assays.
- Supplied with datasheet, COA, and SDS for batch-specific validation.
- Recommended storage and reconstitution guidance to preserve activity.
Medchemexpress LLC (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methylpiperidine | 110429-36-2 | MFCD03788781 | 10g
N-Methylparoxetine is a derivative of Paroxetine that induces Apoptosis NSCLC cells by activating mitogen-activated protein kinase ( MAPK) N-Methylparoxetine has antitumor activity[1]
Medchemexpress LLC Neuritin Human N-H 50ug
Recombinant human Neuritin (partial length) with an N-terminal His tag, expressed in E. coli. This ~11 kDa protein promotes neurite outgrowth and synaptic plasticity and is supplied as a lyophilized powder formulated in Tris-NaCl buffer. It is intended for in vitro assays, biochemical characterization, and protein interaction studies; store frozen and follow recommended reconstitution and stabilizer guidelines for best results.
- Expressed in E. coli and supplied with an N-terminal His tag.
- Approximately 11 kDa partial-length protein that promotes neurite growth.
- Purity greater than 95% as determined by reducing SDS-PAGE.
- Lyophilized formulation in 50 mM Tris-HCl, 300 mM NaCl, pH 7.4.
- Stable when stored at -20°C; aliquot and freeze for long-term storage.
- Recommended reconstitution at ≥100 μg/mL with carrier protein for stability.
Medchemexpress LLC N-desmethyl apalutamide | 99.7% | 463.41 g/mol | C20H13F4N5O2S | 1mg
N-Desmethyl apalutamide-d4 is the deuterium-labeled N-Desmethyl-Apalutamide (HY-135331) N-Desmethyl Apalutamide is an active metabolite of Apalutamide N-Desmethyl Apalutamide is a less potent antagonist of the androgen receptor and is responsible for one-third of the activity of Apalutamide The formation of N-Desmethyl Apalutamide mediated predominantly by CYP2C8 and CYP3A4 N-Desmethyl Apalutamide is moderate to strong CYP3A4 and CYP2B6 inducer and has an excellent plasma-proteins bound concentration[1][2][3]
Medchemexpress LLC Acid-PEG3-C2-Boc | 1807539-06-5 | ≥97.0% | 5 G
Acid-PEG3-C2-Boc is a PEG- and Alkyl/ether-based PROTAC linker. It can be utilized in the synthesis of PROTACs for the degradation of EGFR and the inhibition of mTOR. PROTACs are composed of two distinct ligands connected by a linker; one ligand is for an E3 ubiquitin ligase, and the other is for the target protein. PROTACs leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
- PEG- and Alkyl/ether-based PROTAC linker
- Used in the synthesis of PROTACs
- Degrades EGFR
- Inhibits mTOR
- Leverages the intracellular ubiquitin-proteasome system
- Selectively degrades target proteins
eMolecules 128-09-6 | N-Chlorosuccinimide | Key Organics/BIONET | MFCD00005511 | 133.530 | C4H4ClNO2 | 97.000 | ClN1C(=O)CCC1=O | 1mg | 564159782
N-Chlorosuccinimide | Key Organics/BIONET | 128-09-6 | MFCD00005511 | 133.530 | C4H4ClNO2 | 97.000 | ClN1C(=O)CCC1=O | 1mg | 564159782